OBES SURG DOI 10.1007/s11695-015-1656-0
ORIGINAL CONTRIBUTIONS
Bariatric Surgery in Patients with Dialysis-Dependent Renal Failure Anthony B. Mozer 1 & John R. Pender IV 1,2 & William H. H. Chapman 1,2 & Megan E. Sippey 1 & Walter J. Pories 1,2 & Konstantinos Spaniolas 1,2
# Springer Science+Business Media New York 2015
Abstract Background Laparoscopic procedures for the treatment of morbid obesity are commonly offered to patients with comorbidities previously thought to carry prohibitive operative risk. In this study, we reviewed characteristics and perioperative outcomes of patients with dialysis-dependent renal failure (DDRF) who underwent laparoscopic bariatric procedures. Methods The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2006 to 2011 was reviewed. Preoperative characteristics and 30-day outcome data of patients who underwent three common laparoscopic procedures were analyzed using ANOVA and Pearson chi-squared tests. This was presented in part at the 2014 Clinical Congress of the American College of Surgeons. San Francisco, CA. October 2014. * Konstantinos Spaniolas [email protected] Anthony B. Mozer [email protected] John R. Pender, IV [email protected]
Results One hundred thirty-eight patients (52.5 % female) with DDRF and a median body mass index (BMI) of 45.5 kg/m2 were identified; 33.8 % (n=47) underwent laparoscopic banding (LAGB), 48.9 % (n = 68) laparoscopic Roux-en-Y gastric bypass (RYGB), and 16.5 % (n=23) laparoscopic sleeve gastrectomy (LSG). No differences were found among groups in age, prevalence of American Society of Anesthesiology IV classification, BMI, weight, gender, prevalence of diabetes, and vascular or neurologic comorbidities. Total operation time and length of hospital stay were significantly different between groups. Mortality was 0.7 %, and overall morbidity was 5.8 %. The case mix reflected a decrease in LAGB procedures from 45.5 to 23.3 % from 2006–2009 to 2010–2011 and an increase in LSG procedures from 9.1 to 24.7 % (p
ORIGINAL CONTRIBUTIONS
Bariatric Surgery in Patients with Dialysis-Dependent Renal Failure Anthony B. Mozer 1 & John R. Pender IV 1,2 & William H. H. Chapman 1,2 & Megan E. Sippey 1 & Walter J. Pories 1,2 & Konstantinos Spaniolas 1,2
# Springer Science+Business Media New York 2015
Abstract Background Laparoscopic procedures for the treatment of morbid obesity are commonly offered to patients with comorbidities previously thought to carry prohibitive operative risk. In this study, we reviewed characteristics and perioperative outcomes of patients with dialysis-dependent renal failure (DDRF) who underwent laparoscopic bariatric procedures. Methods The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2006 to 2011 was reviewed. Preoperative characteristics and 30-day outcome data of patients who underwent three common laparoscopic procedures were analyzed using ANOVA and Pearson chi-squared tests. This was presented in part at the 2014 Clinical Congress of the American College of Surgeons. San Francisco, CA. October 2014. * Konstantinos Spaniolas [email protected] Anthony B. Mozer [email protected] John R. Pender, IV [email protected]
Results One hundred thirty-eight patients (52.5 % female) with DDRF and a median body mass index (BMI) of 45.5 kg/m2 were identified; 33.8 % (n=47) underwent laparoscopic banding (LAGB), 48.9 % (n = 68) laparoscopic Roux-en-Y gastric bypass (RYGB), and 16.5 % (n=23) laparoscopic sleeve gastrectomy (LSG). No differences were found among groups in age, prevalence of American Society of Anesthesiology IV classification, BMI, weight, gender, prevalence of diabetes, and vascular or neurologic comorbidities. Total operation time and length of hospital stay were significantly different between groups. Mortality was 0.7 %, and overall morbidity was 5.8 %. The case mix reflected a decrease in LAGB procedures from 45.5 to 23.3 % from 2006–2009 to 2010–2011 and an increase in LSG procedures from 9.1 to 24.7 % (p
![[Surgery Meets Nephrology: Opioid Therapy of Patients with Renal Failure].](/assets/img/hold.png)
